Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (18)

2022

  1. Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

    Blood cancer discovery, Vol. 3, Núm. 4, pp. 273-284

2021

  1. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

    The Lancet Haematology, Vol. 8, Núm. 12, pp. e934-e946

2020

  1. Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set

    Blood, Vol. 136, Núm. 26, pp. 3033-3040

2019

  1. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

    Leukemia, Vol. 33, Núm. 1, pp. 159-170

2018

  1. Maintenance Treatment and Survival in Patients with Myeloma: A Systematic Review and Network Meta-analysis

    JAMA Oncology, Vol. 4, Núm. 10, pp. 1389-1397

2017

  1. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Annals of Oncology, Vol. 28, pp. iv52-iv61

2014

  1. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming

    Journal of Immunology, Vol. 193, Núm. 3, pp. 1151-1161

2013

  1. Endothelial colony-forming cells from patients with paroxysmal nocturnal haemoglobinuria are not PIGA mutated

    British Journal of Haematology

  2. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 56-70

  3. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: Data from the RIETE registry

    Respiratory Research, Vol. 14, Núm. 1

2012

  1. Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome

    Biology of Blood and Marrow Transplantation, Vol. 18, Núm. 8, pp. 1295-1301

  2. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease

    Blood, Vol. 119, Núm. 24, pp. 5909-5917

  3. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning

    Haematologica, Vol. 97, Núm. 5, pp. 710-716

  4. Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation AnticytokineTreatment

    Biology of Blood and Marrow Transplantation, Vol. 18, Núm. 3, pp. 406-413

2010

  1. Circulating human b and plasma cells. age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138 plasma cells

    Haematologica, Vol. 95, Núm. 6, pp. 1016-1020

  2. Human peripheral blood B-Cell compartments: A crossroad in B-cell traffic

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1

  3. Single-cell techniques using chromosomally tagged fluorescent bacteria to study Listeria monocytogenes infection processes

    Applied and Environmental Microbiology, Vol. 76, Núm. 11, pp. 3625-3636

2008

  1. Clinical predictors for fatal pulmonary embolism in 15 520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry

    Circulation, Vol. 117, Núm. 13, pp. 1711-1716